Follow the News

FierceHealthcare

Behavioral Health Business

MedCity News

Modern Healthcare

The telehealth services we all relied on during COVID are fading away — but telemedicine may be entering a new era as...

Oregon pharmacies are well stocked with addiction treatments

The U.S. federal government relaxed online drug prescription rules during the pandemic. Now it wants to rein them in

The DEA Relaxed Online Prescribing Rules During Covid. Now It Wants to Rein Them In.

Washington's supply of opioid meds is well above average, study finds

The DEA Relaxed Online Prescribing Rules During Covid. Now It Wants to Rein Them In.

The DEA Relaxed Online Prescribing Rules During Covid. Now It Wants to Rein Them In.

Recent Digital Health Hires & Board Appointments

More than 40% of pharmacies don't have buprenorphine in stock, study finds

Behind the DEA’s reversal on telemedicine: industry pressure

Less Than 60% of US Pharmacies Stock Buprenorphine for SUD, Creating Multiple Treatment Deserts

CNN CEO Chris Licht’s ouster means women now run all major U.S. news networks. Why it matters

Buprenorphine Access Varies Widely By State, Chain Pharmacies

The DEA needs to officially allow telehealth prescribing for opioid use disorder

Business Briefs: Discovery Behavioral Health, Bicycle Health, Elevance Health Foundation

Bicycle Health's New COO Bringing Brick-and-Mortar Experience, Scale Mindset to Virtual SUD Provider

Nuance's mysterious pricing, speedier digital health evidence reviews, and new breakthrough devices

Chutes & Ladders—AHIP head steps down; Albertsons snatches CVS Health exec

Acadia Healthcare Adds to C-Suite; Bicycle Nabs One Medical Vet for COO Role

Adonis Rakes In $17.3M to Optimize Providers’ Revenue Cycles

DEA Extends Telehealth Flexibilities 6 Months in a Win for Behavioral Health Advocates

DEA extends COVID telehealth prescribing rules until November

DEA extends telehealth prescribing flexibilities for 6 months

DEA extends flexibilities around remote prescribing, for now

Telehealth Companies Applaud DEA for Delaying Telemedicine Restrictions of Controlled Substances

Virtual Addiction Treatment Providers Go Brick-and-Mortar with DEA Changes Looming

Relying on Primary Care Physicians to Treat Opioid Use Disorder Fails Both Patients and Providers

Digital mental health startups scramble as in-person visit rule looms

With DEA Regulations Looming, Digital Health Investment Plummets to Pre-Pandemic Levels

Proposed DEA restrictions on telehealth will accelerate America’s opioid crisis

Digital Point Solutions Positioned for Value-Based Contracting, But Payers, EAPs and Providers Lack Consensus

Telemedicine Startups Wary of Regulatory Shift in War on Opioid Addiction

Telehealth Helped Decrease Fatal Opioid Overdoses, HHS Finds

The government is cracking down on online prescriptions. Patients with addiction and the startups caring for them are...

Bicycle Health: Alabama’s Experience Shows Need To Amend DEA Buprenorphine Rule

‘The Stakes Couldn’t Be Higher’: How DEA’s Proposal Will Affect Telehealth Controlled Substance Prescribing

The DEA’s new telehealth rules are medical malpractice for people with opioid addiction

Axios Pro: Health Tech Deals

Bicycle Health and Wellpath Collaborate to Provide Therapy for Opioid Use Disorder to the Federal Bureau of Prisons

How the DEA's proposed rules could impact addiction startups

A rising tide lifts all boats

DEA Proposal Jeopardizes Digital Providers, Limits Access to Care, Behavioral Health Insiders Warn

Bicycle Health partners with Bureau of Prisons to provide opioid use disorder treatment at reentry centers

DEA proposed rule on remote prescribing draws criticism

New Collaboration Brings Opioid Use Disorder Treatment to Formerly Incarcerated Patients

DEA's proposed telehealth rules pull back COVID-era remote prescribing flexibilities

Bicycle Health Teams Up with Wellpath, Federal Bureau of Prisons on Virtual MAT Program

Experts sound alarm on 'preventable public health crisis' as virtual prescribing for opioid use disorder now in limbo

Virtual Substance Use Disorder Companies Sound Alarm Over PHE Ending

Expanding Telehealth Access Not Reducing it Will Continue Saving Lives, Mitigating Costs of the Opioid Crisis

As PHE winds down, virtual prescribing of controlled substances is in limbo